LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company's segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products. Cardiac Surgery products include oxygenators, heart-lung machines, autotransfusion, mechanical heart valves and tissue heart valves. The Cardiac Rhythm Management segment is engaged in the development, manufacturing and marketing of products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure. Cardiac Rhythm Management products include high-voltage defibrillators Cardiac Resynchronization Therapy device (CRT-D) and low-voltage pacemakers. The Neuromodulation segment is engaged in the design, development and marketing of neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment resistant depression.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment, Supplies & Distribution - NEC
- Sub-Industry: N/A
- Symbol: LON:LIVN
- CUSIP: N/A
- Web: www.livanova.com/
- 50 Day Moving Avg: GBX 4,929.95
- 200 Day Moving Avg: GBX 4,908.19
- 52 Week Range: GBX 49.50 - GBX 6,300
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Net Margins: 5.04%
- Return on Equity: 2.63%
- Return on Assets: 2.44%
- Average Volume: 1,174 shs.
Frequently Asked Questions for LivaNova PLC (LON:LIVN)
What is LivaNova PLC's stock symbol?
LivaNova PLC trades on the London Stock Exchange (LON) under the ticker symbol "LIVN."
When will LivaNova PLC make its next earnings announcement?
Who are some of LivaNova PLC's key competitors?
Some companies that are related to LivaNova PLC include Baxter International (BAX), Zimmer Biomet Holdings (ZBH), C.R. Bard (BCR), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), STERIS PLC (STE), Bio-Rad Laboratories (BIO), Hill-Rom Holdings (HRC), VWR Corporation (VWR), Integra LifeSciences Holdings Corporation (IART), NuVasive (NUVA), ICU Medical (ICUI), Neogen Corporation (NEOG), Nevro Corp. (NVRO), Haemonetics Corporation (HAE), Inogen (INGN), Halyard Health (HYH) and MiMedx Group (MDXG).
Who are LivaNova PLC's key executives?
LivaNova PLC's management team includes the folowing people:
- Damien McDonald, Chief Executive Officer, Chief Operating Officer, Director
- Vivid Sehgal, Chief Financial Officer
- Michel Darnaud, President - Cardiac Surgery
- Stefano Di Lullo, President - Cardiac Rhythm Management
- Rohan H. Hoare Ph.D., President - Neuromodulation
- Brian Sheridan, Senior Vice President, General Counsel, Company Secretary
- David S. Wise, Senior Vice President - Human Resources & Information Technology
- Edward Andrle, Senior Vice President - Strategy & Business Development
- Pritpal Shinmar, Senior Vice President - Global Market Access
- Douglas J. Manko, Chief Accounting Officer
How do I buy LivaNova PLC stock?
Shares of LivaNova PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is LivaNova PLC's stock price today?
MarketBeat Community Rating for LivaNova PLC (LON LIVN)MarketBeat's community ratings are surveys of what our community members think about LivaNova PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of LivaNova PLC stock can currently be purchased for approximately GBX 50.
Consensus Ratings for LivaNova PLC (LON:LIVN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for LivaNova PLC (LON:LIVN)
(Data available from 6/23/2015 forward)
|10/19/2015||Piper Jaffray Companies||Initiated Coverage||Overweight|
|10/19/2015||Kepler Capital Markets||Reiterated Rating||Hold||GBX 4,500|
Earnings History for LivaNova PLC (LON:LIVN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for LivaNova PLC (LON:LIVN)
Current Year EPS Consensus Estimate: $141.04 EPS
Dividend History for LivaNova PLC (LON:LIVN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for LivaNova PLC (LON:LIVN)Insider Trades by Quarter for LivaNova PLC (LON:LIVN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/17/2016||J. Moore,Daniel||Insider||Sell||1,000||GBX 5,688||£56,880|
|1/15/2016||J. Moore,Daniel||Insider||Sell||1,000||GBX 5,264||£52,640|
Headline Trends for LivaNova PLC (LON:LIVN)
Latest Headlines for LivaNova PLC (LON:LIVN)
LivaNova PLC (LIVN) Chart for Friday, June, 23, 2017